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OBJECTIVE: Ischemia reperfusion injury is partly responsible for the high mortality associated with induced
myocardial injury and the reduction in the full benefit of myocardial reperfusion. Remote ischemic
preconditioning, perconditioning, and postconditioning have all been shown to be cardioprotective.
However, it is still unknown which one is the most beneficial. To examine this issue, we used adult male
Wistar rat ischemia reperfusion models to compare the cardioprotective effect of these three approaches
applied on double-sided hind limbs.
METHODS: The rats were randomly distributed to the following five groups: sham, ischemia reperfusion,
remote preconditioning, remote perconditioning, and remote post-conditioning. The ischemia/reperfusion
model was established by sternotomy followed by a 30-min ligation of the left coronary artery and a
subsequent 3-h reperfusion. Remote conditioning was induced with three 5-min ischemia/5-min reperfusion
cycles of the double-sided hind limbs using a tourniquet.
RESULTS: A lower early reperfusion arrhythmia score (1.50¡0.97) was found in the rats treated with remote
perconditioning compared to those in the ischemia reperfusion group (2.33¡0.71). Meanwhile, reduced infarct
size was also observed (15.27¡5.19% in remote perconditioning, 14.53¡3.45% in remote preconditioning, and
19.84¡5.85% in remote post-conditioning vs. 34.47¡7.13% in ischemia reperfusion, p,0.05), as well as higher
expression levels of the apoptosis-relevant protein Bcl-2/Bax following global (ischemia/reperfusion) injury in in
vivo rat heart models (1.255¡0.053 in remote perconditioning, 1.463¡0.290 in remote preconditioning, and
1.461¡0.541 in remote post-conditioning vs. 1.003¡0.159 in ischemia reperfusion, p,0.05).
CONCLUSION: Three remote conditioning strategies implemented with episodes of double-sided hind limb
ischemia/reperfusion have similar therapeutic potential for cardiac ischemia/reperfusion injury, and remote
perconditioning has a greater ability to prevent reperfusion arrhythmia.
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& INTRODUCTION
Currently, coronary artery disease (CAD) is a leading
cause of death among adults. The timely induction of
coronary reperfusion through thrombolytic therapy or
primary percutaneous coronary intervention (PCI) repre-
sents the most effective strategy to reduce myocardial
infarct size. However, ischemia/reperfusion injury (IRI)
(1), which paradoxically induces myocardial injury and
reduces the full benefit of myocardial reperfusion, may be
partially responsible for the high mortality (2) and incidence
of cardiac failure following acute myocardial infarction
(AMI) (3), which remain as high as 10% and 25%,
respectively, at one year.
Ischemic preconditioning has been recognized as a major
cardioprotective phenomenon for many years (4). In recent
years, it has been found that transient ischemia of a remote
organ or limb, which is termed remote ischemic precondi-
tioning (RIPC), could generate protection for the organ
subsequently challenged by lethal ischemia (5). The dis-
covery of this phenomenon may obviate the need to directly
intervene in the heart to achieve cardioprotection.
Although RIPC has been clinically successful in attenuat-
ing the physiological adverse effects of serial balloon
inflations during percutaneous transluminal coronary
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angioplasty (6), its use as a clinical strategy to attenuate the
undesired pathophysiological consequences of IRI is limited
by the failure to predict the onset of ischemia. Kerendi et al.
(7) demonstrated that transient renal ischemia/reperfusion
(IR) at the end of a prolonged episode of myocardial
ischemia reduced the resultant myocardial infarction size.
Subsequently, Andreka et al. (8) found that using a more
practical stimulus of transient limb ischemia, which was
applied following the induction of myocardial infarction
(remote ischemic postconditioning [RIPostC]), also rendered
a protective effect. Moreover, RIPostC can be used in
humans and appears to be as effective as preconditioning
(9). It was concluded that both methods could provide an
equally protective effect to the vascular endothelium.
By using a porcine model, Schmidt et al. (10) demon-
strated that brief intermittent limb ischemia also delivered
significant protection during the evolution of myocardial
infarction. The authors then introduced a new cardioprotec-
tion strategy called remote ischemic preconditioning
(RPerC). In their study, four 5-min ischemia cycles
alternated with 5-min reperfusion were applied to the limb
during a 40-min period of occlusion of the left anterior
descending coronary artery. Consequently, reduced myo-
cardial infarction, well preserved global systolic and
diastolic function, and protection against arrhythmias were
observed during the phase of myocardial reperfusion. Our
study (11) also showed that three 5-min ischemia cycles
combined with 5-min of reperfusion applied to the double-
sided hind limbs during the 30-min occlusion of the left
coronary artery, which was followed by 180 min of
reperfusion, was able to induce cardioprotection in rats.
Based on the timing of the transient limb ischemia,
protective strategies are classified as remote precondition-
ing, perconditioning, and postconditioning. To our knowl-
edge, all three strategies have the potential to provide
cardioprotection. However, it remains unknown which of
the three is the most effective. Therefore, the aim of this
study was to compare the cardioprotective effect of the three
strategies. In doing so, we established myocardial I/R
models in rats and evaluated the protection of RIPC, RPerC,
and RIpostC against myocardial injury when applied to
double-sided hind limbs.
& METHODS
Animals and surgical preparations
All animals were treated according to the principles
stated in relevant Chinese stipulations on animal experi-
ments and in conformity with the Guide for the Care and
Use of Laboratory Animals published by the United States
National Institutes of Health. Furthermore, the experimental
protocol was approved by the Institutional Animal Care
Committee and Ethical Review Committee of Wuhan
general hospital of Guangzhou command. Adult male
Wistar rats (Laboratory Animal Center, Hubei Center for
Disease Control and Prevention, PR China) weighing 250-
410 g (340¡59 g) were used as experimental animals, and
surgical preparations were adapted from procedures that
we have previously described (12). Specifically, general
anesthesia was induced with an intraperitoneal injection of
10% chloral hydrate at a dose of 3 ml.kg-1. Subsequently,
intubation of the rats was performed through an incision of
the trachea, and ventilation was performed at 3-4 ml.kg-1
per minute with atmospheric air. The chest was opened
through a lower sternal incision. Following pericardiotomy,
a prolene 6-0 suture (Johnson & Johnson, SanLorenzo,
Puerto Rico, USA) was placed under the left coronary artery
(LCA), and a slipknot was tied to establish reversible
coronary artery occlusion. Successful occlusion and reperfu-
sion were identified as described by Johns and Olson (10).
Importantly, the animals were anticoagulated with sodium
heparin (150 U/kg-1) prior to the LCA occlusion. A 24-
gauge catheter was delivered into the left ventricle (LV)
chamber, and the changes in ventricular pressure were
monitored continuously. Anesthesia was maintained using
chloral hydrate (1 ml.min-1.kg-1). At 180 min post-reperfu-
sion, the area of the left ventricle at risk was analyzed with
an injection of 2 ml of 1% Evan’s blue (Sigma, USA) into the
LV after the left coronary artery had been ligated. Finally,
cardiac arrest was established with an intracardiac injection
of 10% KCl, and the hearts were immediately excised
followed by the removal of the right ventricular free wall
from the ventricular mass. Additionally, the LV was cut into
1-2 mm slices perpendicular to the septum from the apex to
the base.
Experimental protocols
The rats were randomly distributed to the following five
groups (Figure 1): 1) the sham group (n = 8) was treated as
the control group and did not undergo occlusion of the
coronary artery; 2) the IR group (n = 12) underwent 30 min
of ischemia by occluding the LCA followed by 180 min of
reperfusion by reopening the LCA; 3) the RIPC group
(n = 12) was treated in the same manner as the IR group with
three 5-min ischemia cycles applied to the limbs by tying the
double-sided hind limbs followed by 5-min of reperfusion
by untying them ahead of cardiac ischemia; 4) the RPerC
group (n = 12) was treated like the RIPC group, but remote
conditioning was applied at the start of the cardiac
ischemia; and 5) the RIPostC group (n = 12) was treated
in the same manner as the RIPC group, but remote
conditioning was applied at the beginning of the cardiac
reperfusion.
The remote stimulus was delivered via tourniquet
blockage of blood flow to the double-sided hind limbs and
featured three 5-min cycles of blocked flow followed by 5
min of the resumption of blood flow. Circulatory arrest in
the limbs was identified by observing the empurpled limb
skin and via vascular Doppler. This method has been
developed and standardized in a previous study employing
RPerC (13,14); in that study, this method was shown to be
reliable and consistent in blocking blood flow in the leg.
Analysis of cardiac rhythm
For the duration of this experiment, no prophylactic
antiarrhythmic drugs were administered, and ventricular
arrhythmia caused by sustained hemodynamic collapse was
treated with interrupted slaps. In addition, every episode
was documented, and the arrhythmic scoring system
described by Curtis (15) was used for scoring based on the
cardiac rhythm for analysis.
Assessment of ventricular function
The LV chambers of all the rats were cannulated with 24-
gauge catheters for measuring the hemodynamic para-
meters, and the catheters were connected to fluid-filled
pressure transducers. Real-time hemodynamic data, includ-
ing LV peak systolic pressure (LVSP) and end-diastolic
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pressure (LVEDP), as well as the maximum and minimum
first derivative of LVSP (¡dP/dtmax), were recorded
continuously using chart 4.0 software and a PowerLab
physiological recorder (AD Instrument, Australia). The
entire time course of the IRI was documented as a digital
file.
Determining the at-risk area and infarct size
Left ventricle slices were incubated in 1% pH 7.4
triphenyltetrazolium chloride (Sigma, USA) for 30 min at
37 C˚ and then fixed in 10% formaldehyde solution for 24 h
and photographed. This procedure was followed by
planimetric quantification using Photoshop software 8.0 in
a blind fashion. The area at risk (AAR) represented the
viable area, and the necrotic area was quantitatively
expressed as a percentage of the left ventricle (AAR/LV),
while the area of necrosis (AN) (infarct size) was expressed
as a percentage of the AAR (AN/AAR).
Analysis of Myocardial Apoptosis-Relevant Proteins
Heart tissue from the AAR was collected at the end of
reperfusion to measure the Bcl-2 and Bax expression ratios.
The expression of apoptosis-relevant proteins, Bcl-2 and
Bax, were determined using the histochemical immunity
method. Staining was performed on heart tissue slices
randomly selected from each group by applying a commer-
cially available kit (Roche, Germany) according to the
manufacturer’s instructions. The tissue sections were
examined microscopically at 6400 magnification, and the
images were captured. The positive distribution rate was
analyzed using the HPIAS-1000 color graphic analysis
system, and based on this result, the ratio of Bcl-2/Bax
expression was calculated.
Calculations and Statistics
All of the data were expressed as means ¡ SE unless
otherwise stated, and statistical analysis was performed with
SPSS 13.0 statistics software for the Windows system (SPSS,
Chicago, IL, USA). For all of the hemodynamic parameters,
comparisons were made by applying a one-way ANOVA for
repeated measurements, and individual comparisons were also
examined with a paired Student’s t-test with the Bonferroni
correction when required. The extent of the MI was corrected
for the area at risk and is expressed as a percentage. In all cases,
p,0.05 was considered statistically significant.
& RESULTS
Mortality and exclusion of animals
Fifty-six rats with successful ligation and relaxation of the
coronary arteries were initially included in the study.
Among these, four died of anesthetic accidents, and five
died of ventricular fibrillation during myocardial ischemia.
Thus, complete data sets were obtained from the remaining
47 rats.
Cardiac rhythm data
In comparison with the sham group, ventricular arrhyth-
mia occurred much more frequently during both of the
periods of cardiac ischemia and reperfusion in all of the
other four groups, whereas ventricular tachycardia, ven-
tricular bigeminy, and trigeminy were commonly observed
among all the groups. During the early reperfusion period,
there was no significant difference between the IR group,
the RIPC group or the RIPostC group. However, the
arrhythmic score of the RPerC group was significantly
lower than that of the IR group (p= 0.043, Figure 2).
Hemodynamic data
During both the periods of ischemia and reperfusion, there
were significant changes observed in the IR group and the
RIPC group compared to the data at baseline. Individual
group data are shown in detail in Table 1. The changes reflect
significant differences among these groups at some time
points.
Figure 1 - Animal experimental protocols and grouping.
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Infarct size study
It was shown that the AAR was comparable among the
five different groups (data not shown). Specifically, there
was no visible ischemic or necrotic area in the hearts of the
rats in the sham group, and additionally no significant
differences were observed in the AAR/LV (p= 0.698) of the
other groups. However, the infarct size in the IR group
(34.74¡5.85) was found to be significantly larger than
those of the RPerC, RIPC, and RIPostC groups (15.27¡5.19,
14.53¡3.45, and 19.84¡5.85, respectively; p,0.05)
(Figure 3).
Analysis of myocardial apoptosis-relevant proteins
It was shown that the expression of Bcl-2 in all three of the
remote limb conditioning groups was higher than that in the
IR group, while the expression of Bax in the three
Figure 2 - Period 1 corresponds to ischemia period and period 2, period 3, period 4, and period 5 represents the periods of 0-30 m, 30-
60 m 60-120 m, 120-180 m post reperfusion, respectively.
Table 1 - Hemodynamic data obtained from each group of rat models at different time points.
Hemodynamic data
Time
point Baseline
30 min after
ischemia
30 min after
reperfusion
60 min after
reperfusion
120 min after
reperfusion
180 min after
reperfusion
LVSPmax(mmHg) Sham 139.2¡18.5 133.6¡19.8 136.4¡28.4 125.2¡24.2 115.7¡23.2 112.7¡26.7
IR 126.4¡18.2 100.5¡19.7** 115.9¡24.9 113.7¡26.0 103.2¡27.4 90.2¡29.2
RIPC 135.5¡23.2 110.4¡44.2 101.6¡33.8 104.1¡36.7 92.7¡40.4 86.5¡34.6
RPerC 148.9¡31.4 113.7¡26.3 114.7¡27.7 109.0¡19.4 108.8¡26.2 95.1¡30.1
RIPostC 148.9¡19.9 107.3¡16.4 114.1¡11.7 113.8¡12.7 111.9¡19.1 106.0¡19.6
LVEDPmin(mmHg) Sham (-7.5)¡7.9 (-3.1)¡8.3 (-2.1)¡9.9 (-8.5)¡10.2 (-5.1)¡8.4 (-4.0)¡6.9
IR (-6.9)¡7.3 (-5.1)¡5.7 (-3.9)¡6.8 (-5.0)¡6.3 (-3.8)¡6.8 (-1.9)¡5.7
RIPC (-11.0)¡3.7 (-0.4)¡7.5 4.6¡7.8* 1.7¡6.5 2.1¡3.7 3.2¡3.7
RPerC (-9.3)¡9.3 (-0.8)¡9.4 (-3.1)¡7.5 (-1.9)¡7.5 (-1.0)¡6.6 0.3¡4.8
RIPostC (-9.0)¡3.1 (-4.1)¡3.6 (-0.9)¡2.3 (-1.0)¡3.4 0.2¡4.5 0.1¡4.6
+dp/dtmax(mmHg/s) Sham 5,366.1¡1,557.9 4,806.4¡1,722.6 5,383.9¡1,988.2 5,195.7¡1,902.7 4,069.3¡1,111.9 3,808.8¡1,237.2
IR 5,421.1¡924.5 2,849.9¡1,188.8 3,963.9¡978.7 3,998.4¡978.7 3,477.9¡1,210.9 2,736.2¡1,212.7
RIPC 5147.7¡1899.5 3732.2¡2447.7 3335.3¡1976.4 3677.8¡2234.4** 3338.1¡2427.8 2815.1¡1845.2
RPerC 5730.5¡1270.0 4149.4¡1792.2 4179.2¡1460.1 3601.6¡1018.3 3510.0¡1193.7 3069.0¡1538.5
RIPostC 5825.3¡1864.3 3357.2¡1058.9 3558.4¡1004.5 3503.2¡1184.0 3518.3¡1256.2 3130.0¡1045.8
-dp/dtmax(mmHg/s) Sham 3759.9¡694.4 3816.9¡910.7 3818.4¡871.2 3714.8¡786.1 2866.4¡1075.8 2553.3¡934.9
IR 3495.3¡692.5 2982.1¡843.9 2740.0¡617.5** 2638.4¡552.6** 2292.0¡850.5 1697.6¡733.1
RIPC 3943.2¡1490.4 2678.9¡1740.9 2419.0¡1132.2 2578.8¡1577.7 2088.9¡1563.7 1958.3¡1428.4
RPerC 4159.0¡969.8 3194.1¡1236.4 2993.2¡1007.6 2899.1¡844.8 2544.9¡917.4 2110.9¡969.7
RIPostC 3916.4¡1543.0 2333.6¡627.8 2725.5¡729.3 2631.2¡652.2 2522.6¡913.2 2149.1¡940.2
Notes: Data are represented as means¡SD. IR, ischemia/reperfusion; RIPC, remote ischemic preconditioning; RPerC, remote ischemic perconditioning;
RPostC, remote ischemic postconditioning; LVSP, left ventricle peak systolic pressure; LVEDP, left ventricular end-diastolic pressure; +dP/dtmax, maximal
rate of increase in intraventricular pressure; -dP/dtmax, maximal rate of decrease in intraventricular pressure. **p,0.05 vs. sham group; *p,0.05 vs. IR
group.
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conditioning groups was lower. Moreover, the differences
of these two apoptosis-relevant proteins between the RIPC
group and the IR group were significant, as were the
differences between the RIPostC and IR groups. Based on
the staining analysis, the ratio of Bcl-2/Bax protein expres-
sion was found to be higher in rats from all three remote
limb conditioning groups compared to those from the IR
group (p= 0.035, 0.048, 0), but with regard to the Bcl-2/Bax
ratio, there was no significant difference among the three
remote limb conditioning groups (Table 2).
& DISCUSSION
Using evidence from a rat myocardial IRI model, this
study indicated that all three remote techniques of transient
IR in double-sided hind limbs (i.e., preconditioning,
perconditioning, and post-conditioning) can induce defini-
tive cardiac protection characterized by reducing the
reperfusion ventricular arrhythmia and the infarct size in
the myocardial areas subject to sustained occlusion of the
LCA followed by reperfusion. RPerC (1.50¡0.97) was
shown to inhibit reperfusion ventricular arrhythmia more
significantly than RIPC and RIPostC (1.83¡1.27 and
2.00¡0.89, respectively).
The potential of reducing the myocardial infarct size
using these three approaches is almost equivalent. These
results were similar to the results reported by Basalay et al.
(16), in which a similar degree of cardioprotection could be
achieved with IR of the remote tissue applied prior to,
during or as late as 10 min after the onset of myocardial
reperfusion. However, this cardioprotective phenomenon,
which results from remote ischemic conditioning, is not
always accompanied by the recovery of the maximum and
minimum first derivative of the left ventricular peak systolic
pressure.
Based on the evidence mentioned above, RPerC is
believed to potentially offer an adjunctive alternative to
maximize the protective effects of RIPostC, and both of
them are clinically applicable. We purposefully delivered
the RPerC therapy at the end of the index ischemia period to
mimic the clinical scenarios, as the therapy is usually carried
out in the late phase of an ischemic episode (17).
Nevertheless, it remains unclear whether more cycles of
remote conditioning would lead to greater protection either
alone or in combination. Unfortunately, the time limitation
of our ischemic duration and the need for early intervention
during reperfusion rendered additional limb conditioning
unachievable in this protocol or most likely clinically
irrelevant.
In contrast, there is much less data on the effect of remote
conditioning on reperfusion arrhythmia. Galagudza et al.
(18) found that Langendorff-perfused rat hearts that
demonstrated persistent ventricular fibrillation following
15 min of reperfusion and a subsequent 30 min of regional
ischemia benefited from postconditioning induced by 2 min
of global ischemia followed by reperfusion. Many studies
have suggested that transient Ca2+ overload could be one
cause of this phenomenon. A proposed mechanism for the
potential of remote conditioning to reduce reperfusion
arrhythmia and myocardial infarct size involves the actions
of adenosine, opening of the mitochondrial KATP channel
and closing of the mitochondrial permeability transition
pore, which are pathways that may also affect the benefits of
preconditioning. Here, we demonstrated that RPerC has the
potential to be an antiarrhythmic therapy for reperfusion-
related arrhythmia.
Cardiac myocytes undergo apoptosis in response to a
myriad of stimuli, including hypoxia, reoxygenation,
acidosis, oxidative stress, glucose deprivation, and meta-
bolic inhibition. Despite the fact that pharmacological
studies have been less consistent, caspase inhibitors were
reported to reduce infarct size by 21%-52% (19). The
intrinsic pathway of myocyte apoptosis is regulated by
Figure 3 - Effects of RIPC, RPerC, and RIPostC on infarct size of rats’ left ventricles. n = 5-6; *P,0.05 vs. IR group.
Table 2 - Data on Bcl-2 and Bax expression obtained from
each group of rats.
Groups Bcl-2 (PU) Bax (PU) Bcl-2/Bax (PU)
IR group 51.3¡3.9 51.8¡5.3 1.003¡0.159
RIPC group 56.9¡2.6 40.3¡6.4 1.463¡0.290*
RPerC group 54.3¡1.4* 43.6¡2.1* 1.255¡0.053*
RIPostC group 56.9¡1.4* 42.9¡13.5* 1.461¡0.541*
Data are expressed as means¡SD. Positive unit is abbreviated as PU.
*p,0.05 vs. IR group.
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members of the Bcl-2 family. Antiapoptotic protein Bcl-2
and Bcl-XL promote cell survival by suppressing the
function of the proapoptotic Bcl-2 proteins, such as Bax.
Bcl-2 has been reported to play an important role in
preconditioning, and exposing the hearts to a short period
of ischemia/reperfusion could lead to the significant
induction of Bcl-2 expression (20). In addition, Bax has also
been reported to be activated in cardiac cells in response to
oxidative stress (21) and during ischemia (22). Thus, it could
be inferred that the cardioprotective effect of RPerC is
related to the Bcl-2 family and could be improved through
higher Bcl-2 expression and lower Bax expression.
Although the actual mechanism through which an episode of
transient IR in an organ or tissue can deliver protection against a
subsequent sustained insult of IRI in a remote organ or tissue is
currently unknown, we demonstrated here that three remote
conditioning strategies are all potential therapeutic alternatives
for cardiac IRI and that RPerC is thought to have the greatest
ability to prevent reperfusion arrhythmia.
Biologically, RPerC characterized in animal experiments
remains a healthy heart phenomenon, and its translation to
clinical practice cannot be taken for granted. In fact, a number of
co-morbidities that are frequently present in patients suffering
from AMI are related to the loss of protection from different
ischemic conditionings (23). Recognizing the potential of RPerC
and understanding its underlying signal transduction may
provide an important cardioprotection paradigm and lead to
clinical interventions (24).
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